Expert Opinion on Drug Metabolism & Toxicology
Volume 20, 2024 - Issue 6
Review
New-generation androgen receptor signaling inhibitors (ARSIs) in metastatic hormone-sensitive prostate cancer (mHSPC): pharmacokinetics, drug-drug interactions (DDIs), and clinical impact
Lorenzo Gasperonia Oncological Pharmacy Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) ‘Dino Amadori’, Meldola(FC), Italy
https://orcid.org/0000-0001-6427-0809View further author information
https://orcid.org/0000-0001-6427-0809View further author information, Emilio Francesco Giuntab Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) ‘Dino Amadori’, Meldola(FC), ItalyCorrespondence[email protected]
https://orcid.org/0000-0002-5383-4469View further author information
https://orcid.org/0000-0002-5383-4469View further author information, , & 